Early Clinical and Radiological Outcomes of Uncemented Fully Coated Stem With Patients of 85 Years and More, Complications and Risks Factor
Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Completed
CT.gov ID
NCT05969366
Collaborator
(none)
79
1
97
0.8
Study Details
Study Description
Brief Summary
Retrospective, single-centre study. Review of patients aged 85 and over who underwent total hip replacement between June 2015 and February 2022.
This is a femoral stem survival study with calculation of the complication rate in this population.
The study does not focus on total hip replacements in the context of trauma. The secondary endpoint was the search for complication risk factors.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
79 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Early Clinical and Radiological Outcomes of Uncemented Fully Coated Stem With Patients of 85 Years and More, Complications and Risks Factor
Actual Study Start Date
:
Jun 1, 2015
Actual Primary Completion Date
:
Apr 1, 2016
Actual Study Completion Date
:
Jul 1, 2023
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| patients 85 yearsold or orlder who hab total hip replacement with uncemented femoral stem
|
Procedure: Total hip arthroplasty
|
Outcome Measures
Primary Outcome Measures
- rate of complication [minimum of 3 months follow up]
survival study, any complications
Secondary Outcome Measures
- risk factor of complications [minimum of 3 months follow up]
Eligibility Criteria
Criteria
Ages Eligible for Study:
85 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- receive total hip arthroplasty with uncemented stem fully hydroxyapatites coated
Exclusion Criteria:
-
trauma context
-
less than 3 month follow up
-
Any surgery of the hip as medical history
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Centre Chirurgical Emile Gallé | Nancy | France | 54000 |
Sponsors and Collaborators
- Central Hospital, Nancy, France
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Olivier ROCHE,
Praticien Hospitalier,
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT05969366
Other Study ID Numbers:
- 2022PI032
First Posted:
Aug 1, 2023
Last Update Posted:
Aug 1, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No